Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cell cycle-targeted therapy].

Anne Hansen Ree1

  • 1Onkologisk avdeling, Det Norske Radiumhospital, 0310 Oslo. a.h.ree@medisin.uio.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|October 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term disease-free survival in young-onset rectal cancer patients surgically treated with curative intent: a retrospective cohort study.

International journal of colorectal disease·2026
Same author

Assessment of 16S rRNA sequencing for analysis of circulating microbial DNA in colorectal cancer patients-proof of concept and early changes during experimental chemoimmunotherapy.

Frontiers in microbiology·2026
Same author

Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.

Oncoimmunology·2026
Same author

MRI versus histopathology in EMVI detection for rectal cancer: prognostic relevance and survival outcomes.

European radiology·2026
Same author

Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial.

The British journal of radiology·2026
Same author

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

ImmunoTargets and therapy·2026

Cancer cells with intact cell cycle checkpoints halt division after radiation. Inhibiting these checkpoints overrides this arrest, potentially enhancing cancer therapy effectiveness.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Context:

  • The cell cycle is a fundamental biological process governing cell division.
  • Cell cycle checkpoints act as surveillance mechanisms to detect and respond to DNA damage.
  • Dysregulation of cell cycle control is a hallmark of cancer.

Purpose:

  • To investigate the role of cell cycle checkpoints in the response of tumor cells to ionizing radiation.
  • To determine if inhibiting cell cycle checkpoint signaling affects tumor cell survival after DNA damage.

Summary:

  • Tumor cells with functional cell cycle checkpoints initiated cell cycle arrest in response to radiation-induced DNA damage.
  • This DNA damage response was circumvented by using a checkpoint signaling inhibitor.
  • The findings highlight the critical role of intact checkpoint function in mediating cellular defense against DNA damage.

Related Experiment Videos

Impact:

  • Cell cycle checkpoints are crucial for tumor cell survival following DNA damage.
  • Targeting cell cycle checkpoints could represent a novel therapeutic strategy in cancer treatment.
  • Pharmacological inhibitors of cell cycle signaling may enhance the efficacy of radiation therapy (radiosensitizers).